Last mentioned: Feb 24, 2026
Tier-2/3 Rollout
Scaling the clinic model to underserved smaller urban markets across India.
Series A Funding
Oncare announces ₹27 Cr raise led by Sky Impact Capital.
Phase 1 Expansion
Targeted entry into major Indian metro cities beyond the capital.
Delhi-based oncology startup Oncare has raised ₹27 crore ($3.2 million) in a Series A funding round led by Sky Impact Capital. The capital will fuel the company's expansion from its current Delhi NCR hub into metro, Tier-2, and Tier-3 cities nationwide.
Oncology startup Oncare has raised ₹27 Crore ($3.2 million) in a Series A funding round led by Sky Impact Capital. The capital will drive the expansion of its specialized clinic network from Delhi NCR into Tier-2 and Tier-3 Indian markets to bridge the gap in cancer care accessibility.
Oncology startup Oncare has raised ₹27 crore ($3 million) in a Series A round led by Sky Impact Capital to scale its specialized clinic network. The funding will facilitate expansion from Delhi NCR into metro and Tier-2/3 cities, addressing critical gaps in accessible cancer treatment.